HALEOS LABS
Quarterly Results Analysis [Mar2026]
HALEOS LABS Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹75 Cr | ₹95 Cr | ₹81 Cr | ₹83 Cr | ₹89 Cr | ₹85 Cr | ₹78 Cr | ₹93 Cr |
| Expenses | ₹71 Cr | ₹81 Cr | ₹68 Cr | ₹71 Cr | ₹82 Cr | ₹72 Cr | ₹70 Cr | ₹76 Cr |
| Operating Income | ₹4 Cr | ₹14 Cr | ₹14 Cr | ₹12 Cr | ₹7 Cr | ₹13 Cr | ₹9 Cr | ₹16 Cr |
| Other Income | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr |
| Interest | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| Profit Before Tax | ₹1 Cr | ₹9 Cr | ₹8 Cr | ₹7 Cr | ₹4 Cr | ₹7 Cr | ₹5 Cr | ₹11 Cr |
| Profit After Tax | ₹0 Cr | ₹7 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹3 Cr | ₹7 Cr |
| EPS | ₹1.44 | ₹21.89 | ₹20.19 | ₹13.75 | ₹9.83 | ₹18.08 | ₹15.46 | ₹22.99 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HALEOS LABS | 9% | -9.9% | -1.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -2.3% | 8% |
| DIVIS LABORATORIES | 2% | -2.2% | 1.5% |
| TORRENT PHARMACEUTICALS | -1.8% | -0.1% | 36.7% |
| CIPLA | -2% | -3.3% | -9.9% |
| DR REDDYS LABORATORIES | -0.6% | -3.8% | -6.9% |
| MANKIND PHARMA | 1.5% | -6.4% | 1% |
| LUPIN | 3.5% | 3% | 16.4% |
| ZYDUS LIFESCIENCES | -1.6% | 2.9% | 10.2% |
HALEOS LABS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -20.73 % |
| Y-o-Y | -15.68 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹75 Cr | -20.73 | |
| Dec2025 | ₹95 Cr | 16.49 | |
| Sep2025 | ₹81 Cr | -1.38 | |
| Jun2025 | ₹83 Cr | -7.41 | |
| Mar2025 | ₹89 Cr | 5.33 | |
| Dec2024 | ₹85 Cr | 7.82 | |
| Sep2024 | ₹78 Cr | -15.22 | |
| Jun2024 | ₹93 Cr | - | |
HALEOS LABS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -70.39 % |
| Y-o-Y | -43.94 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4 Cr | -70.39 | |
| Dec2025 | ₹14 Cr | 3.51 | |
| Sep2025 | ₹14 Cr | 15.86 | |
| Jun2025 | ₹12 Cr | 57.84 | |
| Mar2025 | ₹7 Cr | -41.82 | |
| Dec2024 | ₹13 Cr | 48.94 | |
| Sep2024 | ₹9 Cr | -47.41 | |
| Jun2024 | ₹16 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -62.62 % |
| Y-o-Y | -33.49 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 5.54% | -62.62 | |
| Dec2025 | 14.82% | -11.15 | |
| Sep2025 | 16.68% | 17.46 | |
| Jun2025 | 14.2% | 70.47 | |
| Mar2025 | 8.33% | -44.76 | |
| Dec2024 | 15.08% | 38.22 | |
| Sep2024 | 10.91% | -38.01 | |
| Jun2024 | 17.6% | - | |
HALEOS LABS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -94.83 % |
| Y-o-Y | -90.12 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹0 Cr | -94.83 | |
| Dec2025 | ₹7 Cr | 3.44 | |
| Sep2025 | ₹6 Cr | 46.70 | |
| Jun2025 | ₹4 Cr | 25.78 | |
| Mar2025 | ₹3 Cr | -28.23 | |
| Dec2024 | ₹5 Cr | 47.11 | |
| Sep2024 | ₹3 Cr | -53.50 | |
| Jun2024 | ₹7 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -93.44 % |
| Y-o-Y | -88.24 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 0.46 % | -93.44 | |
| Dec2025 | 7.01 % | -11.27 | |
| Sep2025 | 7.9 % | 48.78 | |
| Jun2025 | 5.31 % | 35.81 | |
| Mar2025 | 3.91 % | -31.88 | |
| Dec2024 | 5.74 % | 36.67 | |
| Sep2024 | 4.2 % | -45.24 | |
| Jun2024 | 7.67 % | - | |
HALEOS LABS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -93.42 % |
| Y-o-Y | -85.35 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.44 | -93.42 | |
| Dec2025 | ₹21.89 | 8.42 | |
| Sep2025 | ₹20.19 | 46.84 | |
| Jun2025 | ₹13.75 | 39.88 | |
| Mar2025 | ₹9.83 | -45.63 | |
| Dec2024 | ₹18.08 | 16.95 | |
| Sep2024 | ₹15.46 | -32.75 | |
| Jun2024 | ₹22.99 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD